BrainAurora Controlling Shareholder Extends Lock-Up on 20% Stake to 2027

BrainAurora Medical Technology Limited ( (HK:6681) ) just unveiled an update.

BrainAurora Medical Technology Limited announced that its controlling shareholder ZTan Limited, wholly owned by chairman and executive director Tan Zheng, has voluntarily agreed to an additional lock-up on 275,468,000 shares, representing about 20.28% of the company’s issued share capital, until 5 February 2027. The board emphasized that this extended lock-up, which applies only to ZTan Limited’s direct shareholding, signals strong confidence in BrainAurora’s long-term development and is intended to demonstrate sustained support for the Group’s long-term value and prospects, potentially reinforcing market perception of shareholder alignment and stability in the company’s ownership structure.

The most recent analyst rating on (HK:6681) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on BrainAurora Medical Technology Limited stock, see the HK:6681 Stock Forecast page.

More about BrainAurora Medical Technology Limited

BrainAurora Medical Technology Limited is a Cayman Islands-incorporated medical technology company listed on the Hong Kong Stock Exchange (Stock Code: 6681). The Group focuses on developing and commercialising healthcare technologies, with its operations and governance overseen by a board comprising executive, non-executive and independent non-executive directors.

Average Trading Volume: 20,470,558

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$5.5B

Find detailed analytics on 6681 stock on TipRanks’ Stock Analysis page.